fbpx Back to Top

Neurotrophic Keratitis

Get Help with Your Treatment

Apply Online or call 1-866-316-7263

 

Program Status

Currently Closed – We are no longer accepting or processing applications for new or renewal patients.

 

The PAN Foundation’s Neurotrophic Keratitis fund is currently closed. As of October 17, 2019, National Organization for Rare Disorders is accepting applications.

 

For current information, log in to FundFinder.

 

Assistance Amount

$4,000 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

  1. The patient must be getting treatment for neurotrophic keratitis.
  2. The patient must have Medicare health insurance that covers his or her qualifying medication or product.
  3. The patient’s medication or product must be listed on PAN’s list of covered medications.
  4. The patient’s income must fall at or below 500% of the Federal Poverty Level.
  5. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
list icon
See the list of medications covered in this program
View List  
  • Acetadote (acetylcysteine)
  • Acticlate (doxycycline hyclate)
  • Adoxa (doxycycline monohydrate)
  • Alrex (loteprednol etabonate)
  • Avidoxy (doxycycline monohydrate)
  • Besivance (besifloxacin hcl)
  • Botox (onabotulinumtoxina)
  • Botox Cosmetic (onabotulinumtoxina)
  • Cetraxal (ciprofloxacin hcl)
  • Ciloxan (ciprofloxacin hcl)
  • Cipro (ciprofloxacin hcl)
  • Ciprofloxacin Hcl (ciprofloxacin hcl)
  • Depo-provera (medroxyprogesterone acetate)
  • Dexamethasone Sodium Phosphate (dexamethasone sodium phosphate)
  • Doryx (doxycycline hyclate)
  • Doxy 100 (doxycycline hyclate)
  • Doxycycline Hyclate (doxycycline hyclate)
  • Doxycycline Ir-dr (doxycycline monohydrate)
  • Doxycycline Monohydrate (doxycycline monohydrate)
  • Dysport (abobotulinumtoxina)
  • Flarex (fluorometholone acetate)
  • Fluorometholone (fluorometholone)
  • Fml Forte (fluorometholone)
  • Fml S.o.p. (fluorometholone)
  • Gentak (gentamicin sulfate)
  • Iluvien (fluocinolone acetonide)
  • Inveltys (loteprednol etabonate)
  • Isopto Atropine (atropine sulfate)
  • Jeuveau (prabotulinumtoxina-xvfs)
  • Levofloxacin (levofloxacin)
  • Lotemax (loteprednol etabonate)
  • Loteprednol Etabonate (loteprednol etabonate)
  • Mondoxyne Nl (doxycycline monohydrate)
  • Monodox (doxycycline monohydrate)
  • Morgidox (doxycycline hyclate)
  • Moxeza (moxifloxacin hcl)
  • Ocuflox (ofloxacin)
  • Okebo (doxycycline monohydrate)
  • Omnipred (prednisolone acetate)
  • Oracea (doxycycline monohydrate)
  • Oxervate (cenegermin-bkbj)
  • Pred Forte (prednisolone acetate)
  • Pred Mild (prednisolone acetate)
  • Prednisolone Acetate (prednisolone acetate)
  • Prednisolone Sodium Phosphate (prednisolone sodium phosphate)
  • Prokera (amniotic membrane tissue)
  • Provera (medroxyprogesterone acetate)
  • Retisert (fluocinolone acetonide)
  • Soloxide (doxycycline hyclate)
  • Targadox (doxycycline hyclate)
  • Tobradex (tobramycin/dexamethasone)
  • Tobrex (tobramycin)
  • Vibramycin (doxycycline calcium)
  • Vibramycin (doxycycline hyclate)
  • Vibramycin (doxycycline monohydrate)
  • Vigamox (moxifloxacin hcl)
  • Xeomin (incobotulinumtoxina)
  • Yutiq (fluocinolone acetonide)
  • Zylet (tobramycin/loteprednol etabonate)
  • Zymaxid (gatifloxacin)

Diagnosis Codes:

ICD-10: H16.231, H16.232, H16.233, H16.239

 

About the Disease:

Neurotrophic keratitis, also known as, neurotrophic keratopathy, is a rare degenerative disease of the cornea characterized by reduction or loss of corneal sensitivity. It affects the nervous system.

 

Source: National Institutes of Health

Related Organizations: